Trial intelligence / Profile preview

Perioperative intravenous insulin vs GIK vs GLP-1 in type 2 diabetes during non-cardiac surgery

2012-005291-34Phase 4Completed

Sponsor
AMC Health
Start
Aug 2013
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of liraglutide, human insulin in type 2 diabetes mellitus (T2DM), sponsored by AMC Health. Started Aug 2013; status: completed.

02

Drugs

liraglutidehuman insulin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2012-005291-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005291-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call